ANXA2 also interacts with CXCL12 (SDF1), a BMP9-inducible protein in endothelial cells [55] and a well-defined homing molecule identified for improved stem cell treatments in heart disease [74,91–93]. Here, CXCL12 is linked to heart disorder.